Drug Type Small molecule drug |
Synonyms DS 96432529, DS-96432529 |
Target |
Mechanism CDK8 inhibitors(Cyclin-dependent kinase 8 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H26N4O3S |
InChIKeyGOAKYBVMJUXOFY-LBPRGKRZSA-N |
CAS Registry2871872-79-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone Diseases, Metabolic | Preclinical | JP | 09 Sep 2021 |